Primer for nucleic acid detection

• US 7,709,626 B2
• Filed: 11/10/2008
• Issued: 05/04/2010
• Est. Priority Date: 01/03/2005
• Status: Expired due to Fees

• Current Assignee: United States Department Of Health And Human Services (Government of the United States of America)
• Original Assignee: United States Department Of Health And Human Services (Government of the United States of America)
• Inventors: Narayanan, Jothikumar, Hill, Vincent
• Primary Examiner(s): Kim; Young J
• Assistant Examiner(s): Woolwine; Samuel C
• Application Number:
  US12/267,869
• Publication Number:
  US 20090118490A1
• Time in Patent Office: 540 Days
• Field of Search: None
• US Class Current: 536/24.3
• CPC Class Codes: C12Q 1/6816 characterised by the detection means C12Q1/6804 takes precedence
• CPC Class Codes: C12Q 1/6818 involving interaction of two or more labels, e.g. resonant energy transfer
• CPC Class Codes: C12Q 1/6851 Quantitative amplification
• CPC Class Codes: C12Q 2525/161 incorporating target specific and non-target specific sites
• CPC Class Codes: C12Q 2525/185 incorporating bases where the precise position of the bases in the nucleic acid string is important
• CPC Class Codes: C12Q 2565/101 Interaction between at least two labels
• CPC Class Codes: C12Q 2565/107 Alteration in the property of hybridised versus free label oligonucleotides
• CPC Class Codes: C12Q 2565/113 based on agglutination/precipitation

Abstract

This application provides universal labeled primers for detection and amplification of nucleic acid molecules. These universal primers can be attached to the 5′-end of a target sequence-specific primer. In particular examples, the universal primer includes a labeled nucleotide flanked on both sides a nucleotide whose complement nucleotides changes a detectable signal from the label when the universal primer hybridizes with its complementary nucleic acid molecule. Also disclosed are methods of using the universal primer in nucleic acid amplification, such as real-time PCR.

Claims

1. A method of making a fluorescently-labeled sequence-specific primer, comprising:

adding a universal nucleic acid sequence to a sequence-specific primer, thereby generating a fluorescently-labeled sequence-specific primer,

wherein the universal nucleic acid sequence comprises

a 5′

end,

a 3′

end; and

a fluorescently-labeled nucleotide flanked on each side by at least one nucleotide, wherein nucleotides complementary to the nucleotides flanking the fluorescently-labeled nucleotide quench a detectable signal from the label fluorophore when the fluorescently-labeled sequence-specific primer is hybridized with its complementary nucleic acid molecule and the complementary nucleic acid is synthesized,

wherein the sequence-specific primer can hybridize to a target nucleic acid sequence,

wherein the fluorophore can be quenched by the nucleotides complementary to the nucleotides flanking the fluorescently-labeled nucleotide, and

wherein the universal nucleic acid sequence does not substantially hybridize to the target nucleic acid sequence recognized by the sequence-specific primer.

2. The method of claim 1, wherein the universal nucleic acid sequence comprises the sequence 5′

-X₂X₃X₄X_5(n)-3′

, wherein X₂ and X₄ are “

C”

, X₃ is any nucleotide, and X_5(n) is any number of nucleotides.

3. The method of claim 2, wherein X₃ is “

T”

.

4. The method of claim 2, wherein the X_5(n) is C.

5. The method of claim 2, wherein the sequence 5′

-X₂X₃X₄X_5(n)-3′

, comprises the sequence CTCC.

6. The method of claim 1, wherein the universal nucleic acid sequence comprises the sequence 5′

-CTCSX_(n)-3′

(SEQ ID NO;

     20), wherein X_(n) is any number of nucleotides, wherein S is G or C, and wherein T is the labeled nucleotide and is the second nucleotide from the 5′

-end of the universal nucleic acid sequence.

7. The method of claim 6, wherein n comprises 3-50 nucleotides.

8. The method of claim 6, wherein n comprises 3-20 nucleotides.

9. The method claim 6, wherein n comprises 3-11 nucleotides.

10. The method of claim 6, wherein the universal nucleic acid sequence comprises the sequence 5′

-CTCSXXX-3′

(SEQ ID NO;

     21), wherein X is any nucleotide, wherein S is G or C, and wherein T is the labeled nucleotide and is the second nucleotide from the 5′

-end of the universal nucleic acid sequence.

11. The method of claim 6, wherein the universal nucleic acid sequence comprises the nucleic acid sequence shown in SEQ ID NO:

1, 6, 14, 18, 19, 21, or 22.

12. The method of claim 1, wherein the universal nucleic acid sequence is at least 4 nucleotides.

13. The method of claim 12, wherein the universal nucleic acid sequence is 4 to 25 nucleotides.

14. The method of claim 12, wherein the universal nucleic acid sequence is 4 to 15 nucleotides.

15. The method of claim 1, wherein the universal nucleic acid sequence comprises the sequence 5′

-CTCSXXX_(n)-3′

(SEQ ID NO;

     22), wherein T is the labeled nucleotide and is the second nucleotide from the 5′

-end of the universal nucleic acid sequence and n comprises 0-11 nucleotides.

16. The method of claim 1, wherein the labeled nucleotide is thymidine.

17. The method of claim 1, wherein a signal emitted by the fluorophore is decreased by guanosine in the complementary nucleic acid molecule.

18. The method of claim 1, wherein the fluorophore comprises 6-carboxyfluorescein (6-FAM);

5-carboxyfluorescein (5-FAM);

boron dipyrromethene difluoride (BODIPY);

N,N,N′

,N′

-tetramethyl-6-carboxyrhodamine (TAMRA);

acridine;

stilbene;

6-carboxyfluorescein hexachloride (HEX);

or derivatives thereof.

19. The method of claim 1, wherein a 5′

-end of the sequence-specific primer is added to the 3′

-end of the universal nucleic acid sequence.

20. The method of claim 1, wherein sequence-specific primer comprises at least nine nucleotides.

21. The method of claim 1, wherein the sequence-specific primer comprises a forward primer.

22. The method of claim 1, wherein the sequence-specific primer comprises a reverse primer.

23. A method of making a fluorescently-labeled sequence-specific primer, comprising:

adding a fluorescently-labeled probe sequence to a sequence-specific primer, thereby generating a fluorescently-labeled sequence-specific primer,

wherein the sequence-specific primer can hybridize to a target nucleic acid sequence,

wherein the fluorescently-labeled probe sequence added to the sequence-specific primer comprises 5′

-CTCSSSSX_(n)RRRRGAG-3′

(SEQ ID NO;

31),

wherein X_(n) is any number of nucleotides,

wherein SSSS is complementary to RRRR, and each S is G or C,

wherein T is a fluorescently-labeled nucleotide and is the second nucleotide from the end of the fluorescently-labeled probe sequence,

wherein the CTCSSSS and RRRRGAG sequences of the fluorescently-labeled probe sequence are capable of hybridizing to each other, thereby quenching fluorescence from the fluorescently-labeled T,

wherein the X_(n) sequence is capable of hybridizing to a sequence that would be synthesized by extending the sequence-specific primer on the target nucleic acid sequence, thereby disrupting hybridization between the CTCSSSS and RRRGAG of the probe sequence, thereby increasing the fluorescent signal of the fluorescently-labeled T of the probe sequence.

24. The method of claim 23, wherein the fluorescently-labeled sequence-specific primer comprises 5′

-CTCSSSSX_(n)RRRRGAGZX_(n)-3′

(SEQ ID NO;

32),

wherein X_(n) at position 8 is any number of nucleotides and is capable of hybridizing to a sequence that would be synthesized by extending the sequence-specific primer on the target nucleic acid sequence,

wherein X_(n) at position 17 is any number of nucleotides and is the sequence-specific primer to which the fluorescently-labeled probe sequence was added to generate the fluorescently-labeled sequence-specific primer,

wherein Z is a carbon spacer arm of at least 3 carbons.

25. The method of claim 24, wherein Z is a blocking moiety that can reduce or prevent synthesis of the complementary sequence of the CTCSSSSX_(n)RRRRGAG portion of SEQ ID NO:

32.